What to expect when you take Silvadene and have Diarrhea?

Do you take Silvadene and have Diarrhea? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Dec, 12, 2018

236 reports have been studied.


Females aged 50 to 59 :

136 related reports were analyzed:

Most common symptoms:

Abdominal pain upper
  • 5.15% for females aged 50 (±5) who take Silvadene
Anaemia
  • 22.79% for females aged 50 (±5) who take Silvadene
Anger
  • 5.15% for females aged 50 (±5) who take Silvadene
Angiofibroma
  • 11.76% for females aged 50 (±5) who take Silvadene
Anorectal abscess
  • 13.97% for females aged 50 (±5) who take Silvadene
Areflexia
  • 16.18% for females aged 50 (±5) who take Silvadene
Asthma
  • 5.15% for females aged 50 (±5) who take Silvadene
Autoimmune hepatitis
  • 6.62% for females aged 50 (±5) who take Silvadene
Back pain
  • 22.06% for females aged 50 (±5) who take Silvadene
Balance disorder
  • 5.88% for females aged 50 (±5) who take Silvadene
Bone disorder
  • 16.91% for females aged 50 (±5) who take Silvadene
Bone pain
  • 16.18% for females aged 50 (±5) who take Silvadene
Bronchitis
  • 8.82% for females aged 50 (±5) who take Silvadene
Bursitis
  • 5.15% for females aged 50 (±5) who take Silvadene
Cellulitis
  • 18.38% for females aged 50 (±5) who take Silvadene
Chest wall operation
  • 8.82% for females aged 50 (±5) who take Silvadene
Chronic obstructive pulmonary disease
  • 7.35% for females aged 50 (±5) who take Silvadene
Constipation
  • 18.38% for females aged 50 (±5) who take Silvadene
Cystocele
  • 14.71% for females aged 50 (±5) who take Silvadene
Dental care
  • 8.82% for females aged 50 (±5) who take Silvadene
Dizziness
  • 12.5% for females aged 50 (±5) who take Silvadene
Dry eye syndrome
  • 8.82% for females aged 50 (±5) who take Silvadene
Dry eyes
  • 5.88% for females aged 50 (±5) who take Silvadene
Dysplastic naevus
  • 7.35% for females aged 50 (±5) who take Silvadene
Dyspnea
  • 19.85% for females aged 50 (±5) who take Silvadene
Eating disorder
  • 16.18% for females aged 50 (±5) who take Silvadene
Eczema
  • 11.76% for females aged 50 (±5) who take Silvadene
Emotional distress
  • 16.18% for females aged 50 (±5) who take Silvadene
Excessive granulation tissue
  • 11.76% for females aged 50 (±5) who take Silvadene
Exostosis
  • 16.18% for females aged 50 (±5) who take Silvadene
Eye pain
  • 14.71% for females aged 50 (±5) who take Silvadene
Face injury
  • 11.76% for females aged 50 (±5) who take Silvadene
Faecal incontinence
  • 14.71% for females aged 50 (±5) who take Silvadene
Fall
  • 5.15% for females aged 50 (±5) who take Silvadene
Fatigue
  • 13.24% for females aged 50 (±5) who take Silvadene
Fear
  • 5.15% for females aged 50 (±5) who take Silvadene
Fever
  • 19.12% for females aged 50 (±5) who take Silvadene
Focal segmental glomerulosclerosis
  • 5.15% for females aged 50 (±5) who take Silvadene
Gingival pain
  • 16.18% for females aged 50 (±5) who take Silvadene
Haemangioma
  • 15.44% for females aged 50 (±5) who take Silvadene
Haemorrhage
  • 8.82% for females aged 50 (±5) who take Silvadene
Haemorrhoids
  • 16.18% for females aged 50 (±5) who take Silvadene
Headache
  • 6.62% for females aged 50 (±5) who take Silvadene
Herniated nucleus pulposus (slipped disk)
  • 16.18% for females aged 50 (±5) who take Silvadene
High blood pressure
  • 12.5% for females aged 50 (±5) who take Silvadene
Hypoaesthesia
  • 20.59% for females aged 50 (±5) who take Silvadene
Hypoaesthesia oral
  • 16.18% for females aged 50 (±5) who take Silvadene
Impaired healing
  • 19.85% for females aged 50 (±5) who take Silvadene
Ingrowing nail
  • 16.18% for females aged 50 (±5) who take Silvadene
Injury
  • 19.85% for females aged 50 (±5) who take Silvadene
Insomnia
  • 5.15% for females aged 50 (±5) who take Silvadene
Intervertebral disc operation
  • 8.82% for females aged 50 (±5) who take Silvadene
Intervertebral disc protrusion
  • 16.18% for females aged 50 (±5) who take Silvadene
Joint pain
  • 21.32% for females aged 50 (±5) who take Silvadene
Keratomileusis
  • 8.82% for females aged 50 (±5) who take Silvadene
Lichenoid keratosis
  • 11.76% for females aged 50 (±5) who take Silvadene
Major depression
  • 7.35% for females aged 50 (±5) who take Silvadene
Malignant melanoma
  • 11.76% for females aged 50 (±5) who take Silvadene
Memory loss
  • 16.18% for females aged 50 (±5) who take Silvadene
Metastases to bone
  • 16.18% for females aged 50 (±5) who take Silvadene
Micturition urgency
  • 14.71% for females aged 50 (±5) who take Silvadene
Mitral valve prolapse
  • 16.18% for females aged 50 (±5) who take Silvadene
Musculoskeletal chest pain
  • 6.62% for females aged 50 (±5) who take Silvadene
Nausea
  • 11.03% for females aged 50 (±5) who take Silvadene
Nausea and vomiting
  • 5.15% for females aged 50 (±5) who take Silvadene
Neuralgia
  • 16.18% for females aged 50 (±5) who take Silvadene
Night sweats
  • 16.18% for females aged 50 (±5) who take Silvadene
Nuclear magnetic resonance imaging abnormal
  • 16.18% for females aged 50 (±5) who take Silvadene
Oedema peripheral
  • 16.91% for females aged 50 (±5) who take Silvadene
Oesophageal candidiasis
  • 15.44% for females aged 50 (±5) who take Silvadene
Oral cavity fistula
  • 19.85% for females aged 50 (±5) who take Silvadene
Oral disorder
  • 16.18% for females aged 50 (±5) who take Silvadene
Oral mucosal exfoliation
  • 16.18% for females aged 50 (±5) who take Silvadene
Osteitis
  • 16.18% for females aged 50 (±5) who take Silvadene
Osteoarthritis
  • 14.71% for females aged 50 (±5) who take Silvadene
Osteonecrosis of jaw
  • 17.65% for females aged 50 (±5) who take Silvadene
Pain
  • 27.21% for females aged 50 (±5) who take Silvadene
Pain in extremity
  • 17.65% for females aged 50 (±5) who take Silvadene
Paraesthesia
  • 16.18% for females aged 50 (±5) who take Silvadene
Peripheral arterial occlusive disease
  • 6.62% for females aged 50 (±5) who take Silvadene
Physical disability
  • 16.18% for females aged 50 (±5) who take Silvadene
Plantar fasciitis
  • 13.24% for females aged 50 (±5) who take Silvadene
Pneumonia
  • 7.35% for females aged 50 (±5) who take Silvadene
Posture abnormal
  • 16.18% for females aged 50 (±5) who take Silvadene
Proctalgia
  • 13.97% for females aged 50 (±5) who take Silvadene
Pulmonary embolism
  • 6.62% for females aged 50 (±5) who take Silvadene
Purulent discharge
  • 13.24% for females aged 50 (±5) who take Silvadene
Rectal fissure
  • 13.97% for females aged 50 (±5) who take Silvadene
Rectal haemorrhage
  • 16.18% for females aged 50 (±5) who take Silvadene
Rectocele
  • 14.71% for females aged 50 (±5) who take Silvadene
Renal failure acute
  • 9.56% for females aged 50 (±5) who take Silvadene
Rib fracture
  • 5.15% for females aged 50 (±5) who take Silvadene
Scar
  • 16.91% for females aged 50 (±5) who take Silvadene
Seborrhoeic keratosis
  • 12.5% for females aged 50 (±5) who take Silvadene
Sepsis
  • 6.62% for females aged 50 (±5) who take Silvadene
Seroma
  • 14.71% for females aged 50 (±5) who take Silvadene
Spinal decompression
  • 8.82% for females aged 50 (±5) who take Silvadene
Spinal osteoarthritis
  • 19.85% for females aged 50 (±5) who take Silvadene
Staphylococcal infection
  • 17.65% for females aged 50 (±5) who take Silvadene
Stress and anxiety
  • 23.53% for females aged 50 (±5) who take Silvadene
Surgery
  • 8.82% for females aged 50 (±5) who take Silvadene
Systemic lupus erythematosus
  • 5.15% for females aged 50 (±5) who take Silvadene
Tinnitus
  • 5.15% for females aged 50 (±5) who take Silvadene
Tooth abscess
  • 20.59% for females aged 50 (±5) who take Silvadene
Tooth extraction
  • 8.82% for females aged 50 (±5) who take Silvadene
Tooth loss
  • 20.59% for females aged 50 (±5) who take Silvadene
Toothaches
  • 16.18% for females aged 50 (±5) who take Silvadene
Urinary incontinence
  • 14.71% for females aged 50 (±5) who take Silvadene
Urinary retention
  • 9.56% for females aged 50 (±5) who take Silvadene
Urinary tract infection
  • 22.06% for females aged 50 (±5) who take Silvadene
Varicose vein
  • 6.62% for females aged 50 (±5) who take Silvadene
Walking disability
  • 16.18% for females aged 50 (±5) who take Silvadene
Weakness
  • 16.18% for females aged 50 (±5) who take Silvadene
Weight decreased
  • 8.09% for females aged 50 (±5) who take Silvadene
White blood cell count increased
  • 16.18% for females aged 50 (±5) who take Silvadene
Wound infection
  • 5.15% for females aged 50 (±5) who take Silvadene
Wound infection staphylococcal
  • 16.18% for females aged 50 (±5) who take Silvadene

Most common co-existing conditions:

Asthma
  • 5.88% for females aged 50 (±5) who take Silvadene
Breast cancer
  • 21.32% for females aged 50 (±5) who take Silvadene
Breast cancer metastatic
  • 16.91% for females aged 50 (±5) who take Silvadene
Depression
  • 5.88% for females aged 50 (±5) who take Silvadene
High blood pressure
  • 11.76% for females aged 50 (±5) who take Silvadene
Hypercalcaemia
  • 16.18% for females aged 50 (±5) who take Silvadene
Localised infection
  • 6.62% for females aged 50 (±5) who take Silvadene
Multiple sclerosis
  • 10.29% for females aged 50 (±5) who take Silvadene
Pain
  • 13.24% for females aged 50 (±5) who take Silvadene
Sepsis
  • 5.88% for females aged 50 (±5) who take Silvadene
Sleep disorder
  • 5.15% for females aged 50 (±5) who take Silvadene
Stress and anxiety
  • 5.15% for females aged 50 (±5) who take Silvadene
Systemic lupus erythematosus
  • 5.15% for females aged 50 (±5) who take Silvadene
back to top

Males aged 50 to 59 :

100 related reports were analyzed:

Most common symptoms:

Abdominal pain
  • 6.0% for males aged 50 (±5) who take Silvadene
Abdominal pain upper
  • 5.0% for males aged 50 (±5) who take Silvadene
Acute kidney failure
  • 11.0% for males aged 50 (±5) who take Silvadene
Agitation
  • 5.0% for males aged 50 (±5) who take Silvadene
Anaemia
  • 12.0% for males aged 50 (±5) who take Silvadene
Anhedonia
  • 6.0% for males aged 50 (±5) who take Silvadene
Aortic valve incompetence
  • 7.0% for males aged 50 (±5) who take Silvadene
Arrhythmias
  • 5.0% for males aged 50 (±5) who take Silvadene
Arteriosclerosis coronary artery
  • 5.0% for males aged 50 (±5) who take Silvadene
Atrial fibrillation/flutter
  • 12.0% for males aged 50 (±5) who take Silvadene
Back pain
  • 11.0% for males aged 50 (±5) who take Silvadene
Blister
  • 5.0% for males aged 50 (±5) who take Silvadene
Bronchitis
  • 9.0% for males aged 50 (±5) who take Silvadene
Cardiac failure congestive
  • 20.0% for males aged 50 (±5) who take Silvadene
Cardiomyopathy
  • 7.0% for males aged 50 (±5) who take Silvadene
Cellulitis
  • 11.0% for males aged 50 (±5) who take Silvadene
Chest pain
  • 5.0% for males aged 50 (±5) who take Silvadene
Chronic obstructive pulmonary disease
  • 9.0% for males aged 50 (±5) who take Silvadene
Confusional state
  • 9.0% for males aged 50 (±5) who take Silvadene
Cor pulmonale
  • 6.0% for males aged 50 (±5) who take Silvadene
Coronary heart disease
  • 6.0% for males aged 50 (±5) who take Silvadene
Cough
  • 6.0% for males aged 50 (±5) who take Silvadene
Death
  • 5.0% for males aged 50 (±5) who take Silvadene
Deep venous thrombosis
  • 6.0% for males aged 50 (±5) who take Silvadene
Dehydration
  • 13.0% for males aged 50 (±5) who take Silvadene
Diabetic neuropathy
  • 5.0% for males aged 50 (±5) who take Silvadene
Dizziness
  • 5.0% for males aged 50 (±5) who take Silvadene
Dyspnea
  • 18.0% for males aged 50 (±5) who take Silvadene
Erythema multiforme
  • 8.0% for males aged 50 (±5) who take Silvadene
Fall
  • 15.0% for males aged 50 (±5) who take Silvadene
Fatigue
  • 9.0% for males aged 50 (±5) who take Silvadene
Fever
  • 7.0% for males aged 50 (±5) who take Silvadene
Foot amputation
  • 6.0% for males aged 50 (±5) who take Silvadene
Gangrene
  • 7.0% for males aged 50 (±5) who take Silvadene
Gastroesophageal reflux disease
  • 5.0% for males aged 50 (±5) who take Silvadene
Haematuria
  • 5.0% for males aged 50 (±5) who take Silvadene
Haemorrhoids
  • 5.0% for males aged 50 (±5) who take Silvadene
High blood pressure
  • 5.0% for males aged 50 (±5) who take Silvadene
Hypoaesthesia
  • 6.0% for males aged 50 (±5) who take Silvadene
Impaired healing
  • 10.0% for males aged 50 (±5) who take Silvadene
Impetigo
  • 6.0% for males aged 50 (±5) who take Silvadene
Injury
  • 7.0% for males aged 50 (±5) who take Silvadene
Insomnia
  • 7.0% for males aged 50 (±5) who take Silvadene
Joint pain
  • 13.0% for males aged 50 (±5) who take Silvadene
Left ventricular hypertrophy
  • 5.0% for males aged 50 (±5) who take Silvadene
Malignant neoplasm progression
  • 5.0% for males aged 50 (±5) who take Silvadene
Malnutrition
  • 7.0% for males aged 50 (±5) who take Silvadene
Mental status changes
  • 5.0% for males aged 50 (±5) who take Silvadene
Multiple injuries
  • 7.0% for males aged 50 (±5) who take Silvadene
Musculoskeletal chest pain
  • 5.0% for males aged 50 (±5) who take Silvadene
Myocardial ischaemia
  • 6.0% for males aged 50 (±5) who take Silvadene
Nausea
  • 6.0% for males aged 50 (±5) who take Silvadene
Necrosis
  • 6.0% for males aged 50 (±5) who take Silvadene
Oedema peripheral
  • 12.0% for males aged 50 (±5) who take Silvadene
Pain
  • 14.0% for males aged 50 (±5) who take Silvadene
Pain in extremity
  • 5.0% for males aged 50 (±5) who take Silvadene
Pancytopenia
  • 9.0% for males aged 50 (±5) who take Silvadene
Paroxysmal supraventricular tachycardia
  • 5.0% for males aged 50 (±5) who take Silvadene
Pleural effusion
  • 5.0% for males aged 50 (±5) who take Silvadene
Pneumonia
  • 6.0% for males aged 50 (±5) who take Silvadene
Pulmonary hypertension
  • 7.0% for males aged 50 (±5) who take Silvadene
Rashes
  • 11.0% for males aged 50 (±5) who take Silvadene
Renal failure acute
  • 11.0% for males aged 50 (±5) who take Silvadene
Respiratory acidosis
  • 8.0% for males aged 50 (±5) who take Silvadene
Sepsis
  • 11.0% for males aged 50 (±5) who take Silvadene
Sinus bradycardia
  • 6.0% for males aged 50 (±5) who take Silvadene
Sinus tachycardia
  • 8.0% for males aged 50 (±5) who take Silvadene
Skin ulcer
  • 16.0% for males aged 50 (±5) who take Silvadene
Sleep apnea syndrome
  • 6.0% for males aged 50 (±5) who take Silvadene
Snoring
  • 5.0% for males aged 50 (±5) who take Silvadene
Stable angina
  • 6.0% for males aged 50 (±5) who take Silvadene
Stress and anxiety
  • 16.0% for males aged 50 (±5) who take Silvadene
Thrombocytopenia
  • 17.0% for males aged 50 (±5) who take Silvadene
Urinary tract infection
  • 6.0% for males aged 50 (±5) who take Silvadene
Weakness
  • 14.0% for males aged 50 (±5) who take Silvadene
Weight decreased
  • 9.0% for males aged 50 (±5) who take Silvadene
Wheezing
  • 5.0% for males aged 50 (±5) who take Silvadene
Wound infection
  • 7.0% for males aged 50 (±5) who take Silvadene

Most common co-existing conditions:

Anaemia
  • 5.0% for males aged 50 (±5) who take Silvadene
Appetite - decreased
  • 5.0% for males aged 50 (±5) who take Silvadene
Appetite disorder
  • 5.0% for males aged 50 (±5) who take Silvadene
Atrial fibrillation/flutter
  • 6.0% for males aged 50 (±5) who take Silvadene
Depression
  • 7.0% for males aged 50 (±5) who take Silvadene
Fatigue
  • 5.0% for males aged 50 (±5) who take Silvadene
Headache
  • 5.0% for males aged 50 (±5) who take Silvadene
Lung cancer - non-small cell
  • 6.0% for males aged 50 (±5) who take Silvadene
Nausea
  • 8.0% for males aged 50 (±5) who take Silvadene
Neuropathy peripheral
  • 12.0% for males aged 50 (±5) who take Silvadene
Pain
  • 18.0% for males aged 50 (±5) who take Silvadene
Stress and anxiety
  • 10.0% for males aged 50 (±5) who take Silvadene
Thrombocytopenia
  • 8.0% for males aged 50 (±5) who take Silvadene
Weight decreased
  • 5.0% for males aged 50 (±5) who take Silvadene
back to top

Do you take Silvadene and have Diarrhea:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

silvadene

Silvadene has active ingredients of silver sulfadiazine. (latest outcomes from Silvadene 703 users)

diarrhea

Diarrhea has been reported by people with high blood pressure, multiple sclerosis, rheumatoid arthritis, crohn's disease, multiple myeloma (latest reports from 371,816 Diarrhea patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!